multikinase inhibitor AT9283

DRUG2 trials

Sponsors

Cancer Research UK

Conditions

LeukemiaUnspecified Childhood Solid Tumor, Protocol Specific

Phase 1

AT9283 in Children and Adolescents With Relapsed and Refractory Solid Tumors

CompletedNCT00985868

Cancer Research UKUnspecified Childhood Solid Tumor, Protocol Specific

Start: 2009-09-30End: 2019-11-20Updated: 2019-11-29

AT9283 in Treating Young Patients With Relapsed or Refractory Acute Leukemia

CompletedNCT01431664

Cancer Research UKLeukemia

Start: 2011-09-30End: 2014-07-31Updated: 2014-12-02